Prostate_specific_antigen_after_irradiation_for_prostatic_carcinoma._The_clinical_significance_of_serum_prostate_specific_antigen_after_primary_irradiation_for_adenocarcinoma_of_the_prostate_is_uncertain._Between_September_1986_and_December_1987_serial_prostate_specific_antigen_values_were_determined_in_43_patients_before_and_after_definitive_radiation_therapy._The_study_group_included_6_patients_with_stage_T0d,_10_with_stage_T1,_11_with_stage_T2_and_16_with_stage_T3_disease,_with_a_mean_pre-treatment_prostate_specific_antigen_level_of_49.2_+/-_10.8._For_all_patients_the_first_post-treatment_prostate_specific_antigen_level_was_less_than_the_pre-treatment_level._One_patient_failed_locally_with_recurrent_prostatic_cancer_that_invaded_the_rectum._The_6_patients_who_failed_with_symptomatic_metastases_had_an_increasing_prostate_specific_antigen_level_2_to_7_months_before_detection_of_recurrence._Based_on_the_absolute_value_and_trend_of_the_prostate_specific_antigen,_patients_were_described_as_being_at_high,_intermediate_or_low_risk_for_distant_metastases._Of_9_high,_6_intermediate_and_28_low_risk_patients_4_(44%),_2_(33%)_and_0_(0%)_have_experienced_recurrent_disease_(p_=_0.0025)._We_conclude_that_serial_post-irradiation_prostate_specific_antigen_values_may_be_useful_in_the_early_identification_of_patients_at_risk_for_treatment_failure.